DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer and melanoma in mice through activation of both CD4+ T cells and CD8+ T cells
Open Access
- 1 September 2005
- journal article
- Published by Wiley in Cancer Science
- Vol. 96 (10) , 695-705
Abstract
We report that HSP105, identified by serological identification of antigens by recombinant expression cloning (SEREX), is overexpressed in a variety of human cancers, including colorectal, pancreatic, thyroid, esophageal, and breast carcinoma, but is not expressed in normal tissues except for the testis. The amino acid sequences and expression patterns of HSP105 are very similar in humans and mice. In this study, we set up a preclinical study to investigate the usefulness of a DNA vaccine producing mouse HSP105 whole protein for cancer immunotherapy in vivo using BALB/c and C57BL/6 mice, Colon26, a syngeneic endogenously HSP105‐expressing colorectal cancer cell line, and B16.F10, a melanoma cell line. The DNA vaccine was used to stimulate HSP105‐specific T‐cell responses. Fifty percent of mice immunized with the HSP105 DNA vaccine completely suppressed the growth of subcutaneous Colon26 or B16.F10 cells accompanied by massive infiltration of both CD4+ T cells and CD8+ T cells into tumors. In cell transfer or depletion experiments we proved that both CD4+ T cells and CD8+ T cells induced by these vaccines play critical roles in the activation of antitumor immunity. Evidence of autoimmune reactions was not present in surviving mice that had rejected tumor cell challenges. We found that HSP105 was highly immunogenic in mice and that the HSP105 DNA vaccination induced antitumor immunity without causing autoimmunity. Therefore, HSP105 is an ideal tumor antigen that could be useful for immunotherapy or the prevention of various human tumors that overexpress HSP105, including colorectal cancer and melanoma. (Cancer Sci 2005; 96: 695 – 705)Keywords
This publication has 38 references indexed in Scilit:
- Primary Antitumor Immune Response Mediated by CD4+ T CellsImmunity, 2005
- Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA‐A*0201‐restricted epitopesInternational Journal of Cancer, 2003
- Head and neck cancer antigens recognized by the humoral immune systemBiochemical and Biophysical Research Communications, 2002
- High‐level expression of naked DNA delivered to rat liver via tail vein injectionThe Journal of Gene Medicine, 2002
- Interaction of Heat Shock Proteins with Peptides and Antigen Presenting Cells: Chaperoning of the Innate and Adaptive Immune ResponsesAnnual Review of Immunology, 2002
- Role of hsp105 in Protection against Stress-Induced Apoptosis in Neuronal PC12 CellsBiochemical and Biophysical Research Communications, 2001
- Modulation of the Chaperone Activities of Hsc70/Hsp40 by Hsp105α and Hsp105βBiochemical and Biophysical Research Communications, 2000
- Association of HSP105 with HSC70 in High Molecular Mass Complexes in Mouse FM3A CellsBiochemical and Biophysical Research Communications, 1998
- Cloning and Expression of Murine High Molecular Mass Heat Shock Proteins, HSP105Journal of Biological Chemistry, 1995
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991